-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PymX0SoJ8KjOTwOcigEqs04rjIwI8rEhmZ1BbpWPogbOHWS3x3ze1m/hyfXJCn72 tN9+StCpA2MQpmZ55wrZMA== 0001104659-04-040882.txt : 20041222 0001104659-04-040882.hdr.sgml : 20041222 20041222141815 ACCESSION NUMBER: 0001104659-04-040882 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041220 FILED AS OF DATE: 20041222 DATE AS OF CHANGE: 20041222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZANTE GREG CENTRAL INDEX KEY: 0001264949 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 041220266 MAIL ADDRESS: STREET 1: C/O SANGAMO BIOSCIENCES, INC STE-A-100 STREET 2: POINT RICHMOND TECH, 501 CANAL BLVD, CITY: RICHMOND STATE: CA ZIP: 94804 4 1 a4.xml 4 X0202 4 2004-12-20 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001264949 ZANTE GREG C/O SANGAMO BIOSCIENCES INC., STE 100-A POINT RICHMOND TECH CNTR, 501 CANAL BL RICHMOND CA 94804 0 1 0 0 Sr. Director Finance & Admin Employee Stock Option (Right to Buy) 5.19 2004-12-20 4 A 0 20000 0 A 2014-12-19 Common Stock 20000 20000 D Option is immediately exercisable, subject to repurchase of the option shares by the Issuer at the exercise price prior to full vesting. The repurchase right lapses, and the options vest, as follows: (i) 25% of the option shares on August 19, 2005, and (ii) the remaining shares vest in a series of successive monthly installments over the remaining 36 months thereafter. /s/ Greg Zante 2004-12-20 -----END PRIVACY-ENHANCED MESSAGE-----